Abstract

CD45 is a receptor-type protein-tyrosine phosphatase (PTP) that is required for antigen-specific stimulation and proliferation in lymphocytes. This study was designed to determine the nature of specific kinases in lymphocytes that phosphorylate CD45 and to determine the effect of phosphorylation on CD45 PTP activity. A major cytoplasmic lymphocyte kinase that phosphorylated CD45 was identified as casein kinase 2 (CK2) by use of an in-gel kinase assay in combination with immunoprecipitation, immunodepletion, and specific inhibition. Mutational analysis of CK2 consensus sites showed that the target for CK2 was in an acidic insert of 19 amino acids in the D2 domain, and Ser to Ala mutations at amino acids 965, 968, 969, and 973 abrogated CK2 phosphorylation of CD45. CK2 phosphorylation increased CD45 activity 3-fold toward phosphorylated myelin basic protein, and this increase was reversible by PP2A treatment. Mutation of Ser to Glu at the CK2 sites had the same effect as phosphorylation and also tripled the Vmax of CD45. CD45 isolated in vivo was highly phosphorylated and could not be phosphorylated by CK2 without prior dephosphorylation with phosphatase PP2A. We conclude that CK2 is a major lymphocyte kinase that is responsible for in vivo phosphorylation of CD45, and phosphorylation at specific CK2 sites regulates CD45 PTP activity.

Highlights

  • The role of CD45 protein-tyrosine phosphatase (PTP)1 in lymphocyte signaling has been the subject of extensive investigation [1,2,3,4]

  • A major cytoplasmic lymphocyte kinase that phosphorylated CD45 was identified as casein kinase 2 (CK2) by use of an in-gel kinase assay in combination with immunoprecipitation, immunodepletion, and specific inhibition

  • We have identified CK2 as a lymphocyte kinase that targets CD45 and that is responsible for phosphorylation of CD45 in the 19-amino acid acidic region of the D2 domain of CD45

Read more

Summary

MODULATION OF ACTIVITY AND MUTATIONAL ANALYSIS*

We conclude that CK2 is a major lymphocyte kinase that is responsible for in vivo phosphorylation of CD45, and phosphorylation at specific CK2 sites regulates CD45 PTP activity. We have identified CK2 as a lymphocyte kinase that targets CD45 and that is responsible for phosphorylation of CD45 in the 19-amino acid acidic region of the D2 domain of CD45. This region is a unique insert in the D2 domain that is not found in the CD45 D1 domain or in any other PTP D1 or D2 domain. Investigation of the relationship of the CK2 phosphorylation sites to the PTP activity of CD45 showed that phosphorylation of the D2 acidic region by CK2 increased CD45 activity 3-fold toward phosphorylated myelin basic protein

EXPERIMENTAL PROCEDURES
RESULTS
TABLE I
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.